OHSU in the news

Brushing with Bacteria: The Debate Over a GMO Tooth Microbe

Undark April 17, 2024
In a story about genetically engineered bacteria designed to prevent cavities, Jonathan Baker, Ph.D., expresses concern that the new bacteria have the potential to be transmitted between household family members, and, particularly, between parents and their children.

Combating Health Disparities within Indigenous Communities Amid Cancer Treatment

Hematology/Oncology Pharmacy Association News April 15, 2024
Claymore Kills First, Pharm.D., discusses his first-hand knowledge of how health disparities affect various sovereign Indigenous nations across the U.S.: "Access is another factor since most Indigenous people live on or near reservations, which are rural and not near large academic institutions or NCI- or NCCN-designated cancer centers. When referrals are made, there aren’t enough resources to help patients navigate the health care system."

Kelly Caverzagie, MD, to join OHSU School of Medicine

University of Nebraska Medical Center April 15, 2024
Kelly Caverzagie, M.D., will become senior associate dean for education at OHSU, effective July 15. "The OHSU School of Medicine has been a beacon of innovation and creative thinking in medical and biomedical research education. I am honored by this amazing opportunity to join their team and help lead continued growth at OHSU," he says.

Women in Menopause Are Getting Short Shrift

The Atlantic April 14, 2024
The Atlantic covers the lack of treatment options for symptoms of menopause, finding trans care is a field that can inform other conditions impacted by hormones, including menopause. Blair Peters, M.D., says many trans-health providers have also honed their skills in speaking frankly about sexuality.

Oregon study: COVID-19 vaccine not associated with cardiac deaths in healthy young people

Oregon Public Broadcasting April 12, 2024
A new study from the Oregon Health Authority found reassuring evidence that a complication of the COVID-19 vaccine, myocarditis, was not associated with cardiac deaths among previously healthy young people in the 19 months following the initial vaccine rollout. OPB News spoke with Lars Grosse-Wortmann, M.D., who was not involved in the study. He says: "To me, the study is reassuring in the way that they didn’t find a big smoking gun. They didn’t all of a sudden identify a dozen patients where it had that close chronological association with their vaccine. On the other hand, it’s neither big enough nor detailed enough for me to say, ‘This study leads me to think there’s no risk for sudden cardiac death.’”

OHSU Research Finds COVID-19 Vaccines Offer Broad Protection

iHeartMedia April 12, 2024
In a video interview with HCP Live, Ahmad Masri, M.D., discusses a study he co-led examining trends in incidence and outcomes of emergency department visits from 2006 to 2019 related to hypertrophic cardiomyopathy.
See more stories